EP
PLSE icon

Essential Partners’s Pulse Biosciences PLSE Stock Holding History

Essential Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139 Buy
+5
New +$118 ﹤0.01% 2702

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Essential Partners's PLSE Position: Q2 2026 in Review

Essential Partners opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 5 shares worth $139. The stake represents ﹤0.01% of the portfolio and ranks #2702 among its holdings.

106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Essential Partners held 5 shares of Pulse Biosciences worth $139 as of Q2 2026.
  • Pulse Biosciences was a new Essential Partners position in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2702 holding.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.